Orioli Laura, Thissen Jean-Paul
Research Laboratory of Endocrinology, Diabetes, and Nutrition, Institute of Experimental and Clinical Research, UCLouvain, Brussels, Belgium.
Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Front Endocrinol (Lausanne). 2025 Mar 18;16:1554617. doi: 10.3389/fendo.2025.1554617. eCollection 2025.
Myokines are bioactive peptides released by skeletal muscle. Myokines exert auto-, para-, or endocrine effects, enabling them to regulate many aspects of metabolism in various tissues. However, the contribution of myokines to the dramatic changes in glucose homeostasis and muscle mass induced by bariatric surgery has not been established. Our review highlights that myokines such as brain-derived neurotrophic factor (BDNF), meteorin-like protein (Metrnl), secreted protein acidic and rich in cysteine (SPARC), apelin (APLN) and myostatin (MSTN) may mediate changes in glucose homeostasis and muscle mass after bariatric surgery. Our review also identifies myonectin as an interesting candidate for future studies, as this myokine may regulate lipid metabolism and muscle mass after bariatric surgery. These myokines may provide novel therapeutic targets and biomarkers for obesity, type 2 diabetes and sarcopenia.
肌动蛋白是由骨骼肌释放的生物活性肽。肌动蛋白发挥自分泌、旁分泌或内分泌作用,使其能够调节各种组织中代谢的多个方面。然而,肌动蛋白对减肥手术引起的葡萄糖稳态和肌肉质量的显著变化的作用尚未明确。我们的综述强调,诸如脑源性神经营养因子(BDNF)、类陨石蛋白(Metrnl)、富含半胱氨酸的酸性分泌蛋白(SPARC)、apelin(APLN)和肌肉生长抑制素(MSTN)等肌动蛋白可能介导减肥手术后葡萄糖稳态和肌肉质量的变化。我们的综述还将肌连接蛋白确定为未来研究的一个有趣候选对象,因为这种肌动蛋白可能在减肥手术后调节脂质代谢和肌肉质量。这些肌动蛋白可能为肥胖、2型糖尿病和肌肉减少症提供新的治疗靶点和生物标志物。